Background {#Sec1}
==========

Human astroviruses (HAstVs) were first identified in 1975 in stool samples from children with diarrhea. Until recently, the gastrointestinal tract had been considered the main site of infection with particularly severe acute gastroenteritis in children. Recently, highly divergent strains of astroviruses named Melbourne (MLB) and Virginia/Human-Mink-Ovine-like (VA/HMO) were discovered, which are phylogenetically markedly distant from the classic HAstV. These novel HAstVs have been identified as the cause of central nervous infections such as meningitis and encephalitis, especially in immunocompromised children with gastrointestinal symptoms. To date, only one case has been described in which the classic HAstV genotype four has been associated with central nervous system (CNS) infections in a hospitalized infant with severe combined immunodeficiency (SCID) in Switzerland \[[@CR1]\].

Case presentation {#Sec2}
=================

A 16-month-old Caucasian girl presented with prolonged, generalized, repetitive tonic-clonic seizures to our emergency department. She had watery diarrhea with a low-grade fever up to 38.4 °C and new types of seizures 4 days before. Two months earlier, she was admitted to our neuropediatric ward due to suspected generalized seizures. At that time, her psychomotor development and all clinical and laboratory findings, such as cerebrospinal fluid (CSF) status, electroencephalography as well as a cerebral magnetic resonance imaging (MRI) were normal. After a video documentation, a diagnosis of breath-holding spells was made. On admission day, she was unconscious with a generalized tonic-clonic seizure for approximately 20 minutes. At our emergency department, she received 5 mg midazolam buccal and the seizures subsided. She was then transferred to the general pediatric ward under the impression of a febrile seizure. However, during the following hours seizures reoccurred. She received levetiracetam intravenously up to a total dose of 50 mg/kg per day without a lasting effect. Full blood count, electrolytes, ammonia, blood gas analysis, inflammatory markers, and transaminases as well as ophthalmologic assessment were all repeatedly normal (Table [1](#Tab1){ref-type="table"}). On day 2, she still had short generalized seizures and her consciousness deteriorated steadily so that a lumbar puncture was performed. Seizure control was only achieved after the application of phenobarbital (30 mg/kg) and she was then transferred to the pediatric intensive care unit. At that point, electroencephalography showed an encephalopathic picture with a generalized high amplitude theta and delta activity. Seizure activity was not noted. A CSF examination showed no abnormalities. Her glucose level was 60 mg/dl (reference range 40--70 mg/dl), protein level 12.6 mg/dl (reference range 15--45 mg/dl), lactate level 12.4 mg/dl (reference range \< 20 mg/dl), and no cells were present. CSF was also negative for herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2), enteroviruses, and Epstein--Barr virus. Isoelectric focusing showed no oligoclonal bands, but a Reibergram revealed an intrathecal production of immunoglobulin (IgM) and immunoglobulin (IgG) indicating an acute inflammatory process (Table [2](#Tab2){ref-type="table"}). On day 3, she was still somnolent, so that a cerebral MRI was performed which showed no abnormalities. Electrolytes and glucose levels were repeatedly within normal limits (Table [1](#Tab1){ref-type="table"}). On day 4, she gradually became awake, but was very agitated and not able to walk. Electroencephalography revealed a generalized high voltage theta activity, even though she had not received any sedative medication for 72 hours. The results of the stool samples, which were obtained on the third day of her hospitalization, were negative for *Campylobacter*, *Salmonella*, *Shigella*, *Yersinia* species, norovirus, enterovirus, *Rotavirus*, and adenovirus except for HAstV (Table [3](#Tab3){ref-type="table"}). Table 1Blood parametersComplete blood countReference rangeDay of admissionDay 3 Leukocytes6.2--15 × 10^3^/μl5.9 × 10^3^/μl4.6 × 10^3^/μl Erythrocytes4.1--5.0 × 10^12^/μl4.3 × 10^12^/μl4.17 × 10^12^/μl Hemoglobin10.3--12.4 g/l12.0 g/l11.8 g/l Hematocrit26--37%36%33% MCV81--99 fl82 fl80 fl MCH23--28 pg/cell28 pg/cell28 pg/cell MCHC32--36 g/dl33.8 g/dl35.5 g/dl Thrombocytes130--450 × 10^3^/μl267 × 10^3^/μl255 × 10^3^/μl Normoblasts %0.1% Neutrophils %21--67%50% Lymphocytes %20--64%35% Monocytes %5--11%14% Eosinophils %0--4%1% Basophils %0--1%0%Chemistry panelReference rangeDay of admissionDay 3 Urea17--43 mg/dl33 mg/dl11 mg/dl Creatinine0.6--1.1 mg/dl0.44 mg/dl0.37 U/l CK\< 247 U/l75 U/l GOT\< 82 U/l75 U/l49 U/l GPT\< 30 U/l17 U/l15 U/l LDH\< 300 U/l241 U/l CRP\< 0.5 mg/dl\< 0.2 mg/dl\< 0.2 mg/dl Ammonia16--53 μmol/l34.9 μmol/l41.6 μmol/l Magnesium0.77--1.03 mmol/l0.77 mmol/l Potassium3.4--4.5 mmol/l4.0 mmol/l4.3 mmol/l Sodium136--146 mmol/l143 mmol/l141 mmol/l Calcium1.15--1.29 mmol/l1.27 mmol/l1.22 mmol/l Glucose70--105 mg/dl74 mmol/l87 mmol/l Chloride98--106 mmol/l108 mmol/l104 mmol/l HbA1c%\< 6%4.8% Cortisol6.7--22.6 μg/dl22.3 μg/dl ACTH4.7--48.8 pg/ml15.8 pg/ml*ACTH* adrenocorticotropic hormone, *CK* creatine kinase, *CRP* C-reactive protein, *GOT* glutamic oxaloacetic transaminase, *GPT* glutamate-pyruvate transaminase, *HbA1c* glycated hemoglobin, *LDH* lactate dehydrogenase, *MCH* mean corpuscular hemoglobin, *MCHC* mean corpuscular hemoglobin concentration, *MCV* mean corpuscular volume Table 2Cerebrospinal fluid parametersCerebrospinal fluid results Cell count1/3 /μl Glucose60 mg/dl Protein12.6 mg/dl Lactate12.4 mg/dl Epstein--Barr virus DNANegative Astrovirus PCRPositive Herpes virus 1 and 2Negative EnterovirusesNegative Isoelectric focusingNo sign of oligoclonal bands (serum and CSF) ReibergramAcute inflammatory process with intrathecally produced IgG and IgM, normal CSF barrier function*CSF* cerebrospinal fluid, *IgG* immunoglobulin G, *IgM* immunoglobulin M, *PCR* polymerase chain reaction Table 3Stool parametersStool results *Campylobacter* antigen (ELISA)Negative Astrovirus antigen (ELISA)Positive Adenovirus Antigen (ELISA)Negative Norovirus (PCR)Negative *Rotavirus* (PCR)Negative *Salmonella* (stool culture)Negative *Shigella* (stool culture)Negative *Yersinia* species (stool culture)Negative *Clostridium difficile* PCR (toxin A + B)Negative*ELISA* enzyme-linked immunosorbent assay, *PCR* polymerase chain reaction

We then hypothesized an astrovirus-related CNS infection and tested the initially obtained CSF sample for the virus. Sanger sequencing revealed a classic genotype HAstV-1 with the same nucleotide sequence in both samples (Fig. [1](#Fig1){ref-type="fig"}). Initially, we considered a therapy with intravenous immunoglobulin (IVIG) ± methylprednisolone, but abstained from it due to her fast and good clinical improvement \[[@CR2]\]. Over the following days, she improved gradually, the electroencephalography normalized and on day 9 she was discharged. On follow-up over the next 6 months she showed a normal sensorimotor development without any signs of neurological impairment. Despite extensive investigations, we could not identify the source of the infection in this case. Most commonly described reservoirs and sources of infection for humans include fruits, vegetables, and water \[[@CR2]\]. Fig. 1The phylogenetic tree of a 410 bp alignment of the ORF1b region of human astrovirus identified from the patient (18-G0568) belongs to the classic human astrovirus genotype human astrovirus-1. The tree was constructed using the Maximum Likelihood method and the Tamura-3-parameter method with the Bootstrap test (1000 replicates). For the modeling of the evolutionary rate, a discrete gamma distribution model was used with MEGA 7. Bootstrap values above 70 are shown. Reference sequences obtained from the GenBank are indicated by the accession number, TAstV was used as an outgroup (GenBank EU143843). *HAstV* human astrovirus, *MLB* Melbourne, *TAstV* turkey astrovirus, *VA* Virginia

Discussion and conclusions {#Sec3}
==========================

HAstVs constitute the third most common viral agent of acute diarrhea after *Rotavirus* and norovirus and are responsible for up to 10% of non-bacterial gastroenteritis \[[@CR3]\]. However, the recently discovered highly divergent HAstVs, named MLB and VA/HMO, have been identified as the cause of CNS infections in vulnerable individuals highlighting that these viruses bypass the gastrointestinal tract and infect other tissues and organs \[[@CR4]\]. HAstV-VA1/HMO-C has also been detected in the brain tissue of immunocompromised patients with acute encephalitis. Overall, CNS infection with the newly described HAstVs almost exclusively occurs in immunocompromised patients \[[@CR5]\].

Here, we report the first case of a CNS infection with a classic HAstV in a non-immunocompromised infant. However, common CSF findings of CNS infections such as pleocytosis were in our case completely normal, which is in line with previous reports \[[@CR1]\]. Diagnosis of an astrovirus CNS infection is further complicated by the unreliable detectability of acute IgM antibodies in CSF and the fact that even serum antibodies in the acute phase of infection were detectable only in a few patients \[[@CR6]\]. Therefore, the diagnosis of an acute astrovirus CNS infection currently relies exclusively on the clinical picture, specific detection of astrovirus in the CSF mostly by next-generation sequencing (NGS)-based diagnosis, and exclusion of other known causes for encephalitis, as in this case.

Similar to previous reports on immunocompromised patients and infection of HAstV-MLB or VA strains, the most probable route of infection was enteric inoculation followed by viral translocation and infection of the CNS via the bloodstream. In previous case reports, HAstV-VA1 was found in neurons and astrocytes \[[@CR7]\]. A recent publication showed for the first time that the novel described HAstV-VA1 could be propagated in cell culture without trypsin, which was mandatory for the cell culture of classic HAstV strains. The authors supposed that classic and novel HAstV genotypes react differently toward trypsin for the proteolytic cleavage of the viral capsid. This may influence the contribution of the tissue tropism of HAstVs and novel HAstV strains might spread toward tissues with low trypsin levels; however, so far the mechanism of neuroinvasion of HAstV remains unclear \[[@CR8]\]. Interestingly, CNS infections in mammals such as swine, sheep, and cattle seem to be quite common \[[@CR9]\].

We therefore believe that in the future the possibility of HAstV CNS infection needs to be considered on a routine basis in non-immunocompromised infants and young children with sensitive detection systems covering all HAstV species (classic HAstV genotypes 1 to 8 as well as HAstV-MLB and VA strains). Even though there are currently no specific therapeutic options available, the identification of the causative agent in an encephalopathic child is of utmost importance -- for the community to implement prophylactic actions and even more for the parents who always seek to obtain an explanation -- in particular, in possibly very debilitating diseases such as encephalopathy/encephalitis.
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